Not for Intrathecal Use
Risk with Inadvertent Intrathecal Administration for Intra-Arterial and Intravemous Use Only
- Inadvertent intrathecal administration may cause death, convulsions, cerebral hemorrhage, coma, paralysis, arachnoiditis, acute renal failure, cardiac arrest, seizures, rhabdomyolysis, hyperthermia, and brain edema.
Patient counseling
Package inserts
Keywords: Optiray
Updated: December 2020